ClareChui LingSunMD

PubMed

• 61 citations
  Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
  Mika Shapiro, Yair Herishanu, Ben-Zion Katz, Nili Dezorella, Clare Sun
  Haematologica. 2017-05-01
• 55 citations
  Molecular map of chronic lymphocytic leukemia and its impact on outcome.
  Binyamin A Knisbacher, Ziao Lin, Cynthia K Hahn, Ferran Nadeu, Martí Duran-Ferrer
  Nature Genetics. 2022-11-01
• 59 citations
  Anal fistula plug and fibrin glue versus conventional treatment in repair of complex anal fistulas
  Wiley Chung, Pooya Kazemi, David Ko, Clare Sun, Carl J. Brown
  American Journal of Surgery. 2009-05-01

Abstracts/Posters

• Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T...
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CLL Intraclonal Fractions Defined By Time Since Cell Birth/Division Promote a Leukemia-Supportive, Immune-Tolerant Microenvironment By Distinct Mechanisms 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all